From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
“Our channel models are becoming increasingly complicated. It is critical we have solutions that provide insight into product availability, regardless of the channel model we’re using.”
Vice President | Trade & Channel
Built on ICyte, IntegriChain’s platform features four unique channel management solutions:
Demand data that accurately measures dispensing/administration across all channels
Methodology for month and quarter closing inventory pipeline with minimal assumptions
Accurate measures of dispensing/utilization in blinded and blocked channels
Aggregation solutions that work for distribution data and pharmacy dispensing data
Timelier and more granular patient journey visibility
Diagnostic patient journey analytics
Learn More About ICyte Benchmarks .
Hundreds of manufacturers rely on the ICyte market-tested technology and data science-based algorithms to rapidly and accurately ingest channel data and transform it into an actionable pharma channel strategy for your market access and trade and channel teams.
Our approach to channel data management excellence includes:
ICyte’s data refinement leverages leading-edge data science algorithms and machine learning to deliver best-in-class data stewardship, refinement, and enrichment. This helps to create deeper and faster insights around product availability and the brand’s financial performance.
ICyte analytics provides an end-to-end view of product distribution starting with pharmaceutical supplier distributor inventory, distributor sales, chain DC inventory, store inventory, returns, and POS demand. Based on actual sell-in, returns, and point-of-sale data, IntegriChain provides a weekly report of retail inventories on hand at an individual SKU level. Inventory analytics captures 100% of the inventory located in chain distribution centers, chain stores, and independent stores that house products not yet returned to the manufacturer or wholesaler.
ICyte Data Aggregation
ICyte Order Management
ICyte Data Refinement
ICyte Distribution Contract Management
ICyte Inventory Analytics
ICyte Patient Analytics
Discover Actionable Channel Insights
Insights into specialty lite challenges and a new pharmaceutical distribution channel strategy that has emerged to help manufacturers balance patient access with their gross-to-net
Read the Blog
Biosimilars and specialty generics are the new hot ticket for the pharma industry. However, there may be a rocky road ahead.
Watch the Webinar
